MAPT and Alzheimer disease: Cerebrospinal fluid (CSF) analysis is a well-established method to support a clinical diagnosis of Alzheimer disease (AD), with validated and clinically approved biomarkers for β-amyloid (Aβ) pathology, phosphorylated tau (p-tau), and neurodegeneration.